Literature DB >> 25023210

Acute kidney injury: Mechanism of AKI sensitivity in diabetic nephropathy.

Susan J Allison.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25023210     DOI: 10.1038/nrneph.2014.125

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Hyperglycemia, p53, and mitochondrial pathway of apoptosis are involved in the susceptibility of diabetic models to ischemic acute kidney injury.

Authors:  Jianping Peng; Xiaoning Li; Dongshan Zhang; Jian-Kang Chen; Yunchao Su; Sylvia B Smith; Zheng Dong
Journal:  Kidney Int       Date:  2014-06-25       Impact factor: 10.612

  1 in total
  4 in total

Review 1.  Acute Kidney Injury in Diabetes Mellitus.

Authors:  D Patschan; G A Müller
Journal:  Int J Nephrol       Date:  2016-11-15

2.  2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione isolated from Averrhoa carambola L. root ameliorates diabetic nephropathy by inhibiting the TLR4/MyD88/NF-κB pathway.

Authors:  Shunyu Lu; Hongliang Zhang; Xiaojie Wei; Xiang Huang; Lixiu Chen; Luhui Jiang; Xingchun Wu; Xing Zhou; Luhui Qin; Yuchun Li; Xing Lin; Renbin Huang
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-07       Impact factor: 3.168

3.  Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors.

Authors:  Cheng-Yi Chen; Vin-Cent Wu; Cheng-Jui Lin; Chih-Sheng Lin; Chi-Feng Pan; Han-Hsiang Chen; Yu-Feng Lin; Tao-Min Huang; Likwang Chen; Chih-Jen Wu
Journal:  Mayo Clin Proc       Date:  2018-10-19       Impact factor: 7.616

4.  Hyperglycemia aggravates acute liver injury by promoting liver-resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR-mediated autophagy induction.

Authors:  Qi Wang; Song Wei; Shun Zhou; Jiannan Qiu; Chenyu Shi; Rui Liu; Haoming Zhou; Ling Lu
Journal:  Immunol Cell Biol       Date:  2019-11-19       Impact factor: 5.126

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.